Skip to content

    M K Proteins Limited

    Fast Moving Consumer Goods
    Fast Moving Consumer Goods

    Overview

    Price

    Market Cap

    ₹159 Cr

    Sector

    Fast Moving Consumer Goods

    Fast Moving Consumer Goods

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital4441338383838
    Reserves1525353724323639
    Borrowings312537462039237
    Other Liabilities7131081522418
    Total Liabilities5767861039613180131
    AssetsFixed Assets32333435
    CWIP00006777
    Investments00000040
    Other Assets5365831008812066119
    Total Assets5767861039613180131

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating6-46-10-632-165
    Cash from Investing000-20-6-1-2
    Cash from Financing-74-5126-2718-3
    SummaryCapital Expenditure
    Free Cash Flow6-45-12-627-184
    FCF Margin

    Valuation

    Assumptions

    Current — MKPL
    Price
    ₹5
    EPS (TTM)
    ₹0.17
    PE (TTM)
    28.1
    Profit growth
    -21.7%

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (29.8×) and current (28.1×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹5
    vs
    Fair value · 15% return
    ₹1
    90%Overvalued

    At -21.7% growth and a 28× exit, ₹5 only delivers your return if you pay ₹1. The price is currently baking in 18% growth.

    EPS grows -21.7%/yr for 5 years, then fades to 6% over 2, exits at 28×.

    YearGrowthEPS (₹)
    FY27-21.7%0.13
    FY28-21.7%0.10
    FY29-21.7%0.08
    FY30-21.7%0.06
    FY31-21.7%0.05
    FY32-7.8% ·fade0.05
    FY336.0% ·fade0.05

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse M K Proteins Limited

    Guides on how to read this kind of business and the numbers that matter.